For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Drug‑induced cardiac injury (DICI) detection remains a major safety issue in drug development. While circulating microRNAs (miRs) have emerged as promising translational biomarkers, novel early detection biomarkers of cardiotoxicity are needed to evaluate toxicity in a time-dependent manner.
This webinar will review:
Register today to hear more about this exciting topic and have your questions answered by Dr Glineur and Dr DaCosta during a live Q&A session!
Academic clinicians and pharma researchers who are interested in discovering, validating, and quantifying biomarkers within biofluids and tissues.
Novel use of extracellular vesicles (EVs) in the search for biomarkers
Wednesday, June 15, 2016 | 14:00-15:00 GMT/ 09:00-10:00 EST
Stéphanie holds a DVM and a PhD degree in Veterinary Sciences from the University of Liege (Belgium) and completed a 2.5 year post-doctoral fellowship at the National Institutes of Health in Bethesda (MD, USA). During her professional career, Stéphanie developed a deep expertise in immuno-pathology, genetics and molecular biology.
Stéphanie has over 10 years research experience, including the last 2 years as responsible for microRNA safety biomarker implementation and as a key contributor to mechanistic and investigative toxicology in drug development. She is currently lecturer in Animal Genetics at the Université libre de Bruxelles.
Andre da Costa has a MSc in cell biology from the University of Lisbon, a PhD in molecular Epidemiology and Biomarkers and a Professional Certificate in Biomarkers from the European Society for Translational Medicine. His biomarker activities span safety, efficacy, early detection/diagnosis and patient stratification centered in 3 therapeutic areas: oncology, neurosciences and immunology. He has been involved in biomarker research at the level of discovery, development, validation and implementation of preclinical and clinical biomarkers.
Andre currently leads a biomarker-orientated group which provides preclinical/clinical strategic and scientific support in drug safety, neurosciences and immunology.
Email the Abcam Events Team for the answers.
Learn about the latest research when and where you want to with Abcam's on-demand webinar library!